United Therapeutics Corporation vs Walgreens Boots Alliance, Inc.: A Gross Profit Performance Breakdown

Comparing Profit Trends: United Therapeutics vs. Walgreens Boots Alliance

__timestampUnited Therapeutics CorporationWalgreens Boots Alliance, Inc.
Wednesday, January 1, 2014116263600021569000000
Thursday, January 1, 2015139672500026753000000
Friday, January 1, 2016152610000029874000000
Sunday, January 1, 2017161960000029162000000
Monday, January 1, 2018142910000030792000000
Tuesday, January 1, 2019133120000028159000000
Wednesday, January 1, 2020137520000026077000000
Friday, January 1, 2021156300000028067000000
Saturday, January 1, 2022178960000028266000000
Sunday, January 1, 2023207000000027072000000
Monday, January 1, 202426524000000
Loading chart...

Unveiling the hidden dimensions of data

A Tale of Two Giants: United Therapeutics vs. Walgreens Boots Alliance

In the ever-evolving landscape of corporate profitability, United Therapeutics Corporation and Walgreens Boots Alliance, Inc. stand as intriguing case studies. From 2014 to 2023, these companies have showcased distinct trajectories in gross profit performance. United Therapeutics, a leader in biotechnology, saw its gross profit grow by approximately 78%, peaking in 2023. This growth reflects its innovative strides in the healthcare sector. Meanwhile, Walgreens Boots Alliance, a retail pharmacy titan, experienced a more modest 25% increase over the same period, with a notable peak in 2018. This trend underscores the challenges and opportunities in the retail pharmacy industry, especially in a post-pandemic world. Notably, data for 2024 is missing for United Therapeutics, leaving room for speculation on its future performance. As these companies navigate their respective industries, their financial journeys offer valuable insights into the dynamics of profitability and market adaptation.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025